Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets

Increasing evidence strongly suggests that bevacizumab compound impacts the immunological signature of cancer patients and normalizes tumor vasculature. This study aims to investigate the correlation between the clinical response to bevacizumab-based chemotherapy and the improvement of immune fitnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Napoletano, Chiara, Ruscito, Ilary, Bellati, Filippo, Zizzari, Ilaria Grazia, Rahimi, Hassan, Gasparri, Maria Luisa, Antonilli, Morena, Panici, Pierluigi Benedetti, Rughetti, Aurelia, Nuti, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462947/
https://www.ncbi.nlm.nih.gov/pubmed/30889935
http://dx.doi.org/10.3390/jcm8030380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462947/
https://www.ncbi.nlm.nih.gov/pubmed/30889935
http://dx.doi.org/10.3390/jcm8030380

Ejemplares similares